← Eichor
Study identifier: NCT06492785 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

Condition: Infertility  ·  Sponsor: Northwest Women's and Children's Hospital, Xi'an, Shaanxi

PhaseNA
Planned participants858
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.

This description comes directly from the study's public registry record.

Talk to the study team

He Cai, Doctor  ·  13581613908  ·  caihe@bjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

IVF laboratoryXi'an, Shaanxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06492785